News

Global contract manufacturing organisation (CMO) Symbiosis Pharmaceutical Services has successfully completed its latest inspection by the US Food and Drug...

We’re delighted to announce the expansion of the Symbiosis Business Development team with the addition of two highly experienced U.S....

Symbiosis acquires 20,000 sq/ft facility to increase high-tech manufacturing capabilities, financed by £1.2m from Barclays Corporate Bank PLC. The additional...

Scottish Enterprise celebrates record results for Scottish economy Strongest ever performance on jobs and capital investment Scottish Enterprise delivered a...

Symbiosis Pharmaceutical Services, has launched new in-house analytical and microbiological capabilities to enable testing of small molecule, biological, and Advanced...

Symbiosis has today announced a 1 million GBP (1.2 million Euros, 1.3 million USD) investment in its in-house analytical services...

We are pleased to announce the launch of our new video of the GMP manufacturing facility here at Symbiosis in...

Symbiosis announces the completion of a £1.3 million collaborative UKRI-funded project as part of the medicines manufacturing challenge. Symbiosis and...

Symbiosis is delighted to announce an expansion of its capabilities to handle novel and emerging treatments, such as viral based...

We’re very proud to announce that Symbiosis is working with Modus Therapeutics Holding AB, a company developing innovative treatments for...

Symbiosis Pharmaceutical Services (Symbiosis), a fast-growing Contract Manufacturing Organisation (CMO) specialising in sterile manufacture of vaccines, pharmaceuticals, and biopharmaceuticals, and...

Amazing news for everyone with the confirmation that AstraZeneca’s COVID-19 vaccine has been approved for emergency supply in the UK...